Rankings
▼
Calendar
INVA Q2 2025 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$100M
-3.0% YoY
Gross Profit
$90M
89.4% margin
Operating Income
-$49M
-48.6% margin
Net Income
$64M
63.5% margin
EPS (Diluted)
$0.77
QoQ Revenue Growth
+13.1%
Cash Flow
Operating Cash Flow
$44M
Free Cash Flow
$44M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$619M
Stockholders' Equity
$715M
Cash & Equivalents
$398M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$100M
$103M
-3.0%
Gross Profit
$90M
$85M
+5.6%
Operating Income
-$49M
$55M
-189.1%
Net Income
$64M
-$35M
+283.6%
Revenue Segments
Royalty
$64M
64%
Product
$35M
35%
License And Other Revenue
$910,000
1%
← FY 2025
All Quarters
Q3 2025 →